Press Release Kyverna Therapeutics Reports Pipeline Progress and Second Quarter 2026 Financial Results 12 hours ago
Press Release Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel Jul 27